Doggett Amanda, Belisario Kyla L, McDonald André J, Gohari Mahmood, Leatherdale Scott T, Murphy James G, MacKillop James
Peter Boris Centre for Addictions Research, St. Joseph's Healthcare Hamilton and McMaster University, Canada; Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University and St. Joseph's Healthcare Hamilton, Canada.
Peter Boris Centre for Addictions Research, St. Joseph's Healthcare Hamilton and McMaster University, Canada.
Int J Drug Policy. 2025 Feb;136:104686. doi: 10.1016/j.drugpo.2024.104686. Epub 2024 Dec 27.
Recreational cannabis legalization marked a significant policy shift in Canada, but has been difficult to evaluate because of the absence of a control group. Although it is unfeasible to evaluate legalization using a randomized controlled trial design, sophisticated statistical techniques can employ quasi-experimental designs using natural experiments. This study evaluates the impact of cannabis legalization in a longitudinal cohort of Canadian emerging adults by comparing changes in cannabis use frequency and related consequences over time to changes in a similar cohort in a United States jurisdiction where no policy change took place.
Two samples of emerging adults from Hamilton, Ontario, and Memphis, Tennessee, were followed longitudinally in 4-month intervals from March 16, 2018 to March 11, 2020, with three pre-legalization and four post-legalization assessments. Doubly robust difference-in-difference (DiD) estimation was used to assess whether cannabis legalization impacted cannabis use frequency or cannabis-related consequences in the Canadian sample over time. The impact of cannabis legalization on alcohol use and alcohol-related consequences was also assessed as a control form of substance use for which no policy change took place. Cohort differences were adjusted within DiD estimation using propensity score balancing.
Against a general trend of decreasing use over time, the DiD estimation revealed significantly greater cannabis use frequency approximately 6-months post legalization (ATT (95% CI): 0.2245 (0.0154, 0.4336)) and approximately one year post legalization (ATT (95% CI):0.3091 (0.0473, 0.5709)) in the Canadian sample compared to the American sample. Cannabis-related consequences were also greater in the Canadian sample at both of these time points (ATT (95% CI): 0.0.7610 (0.0797, 1.4423)), (ATT (95% CI): 1.0396 (0.1864, 1.8928)). These higher levels reflected less steep declines over time (i.e., attenuated 'aging out'). Alcohol changes showed no impact of legalization at any time point, as expected.
Findings suggest that cannabis legalization was associated with smaller reductions in cannabis use frequency and adverse consequences than expected in the Canadian sample compared to the American control sample. Although the magnitude of these impacts was small, these findings suggest the start of diverging cannabis trajectories. Given that effects of legalization are hypothesized to be long-term rather than immediate, further monitoring of the impacts of cannabis legalization on developmental trends in cannabis use and related consequences is warranted.
娱乐用大麻合法化标志着加拿大一项重大的政策转变,但由于缺乏对照组,一直难以评估其效果。虽然采用随机对照试验设计来评估合法化不可行,但复杂的统计技术可以运用自然实验的准实验设计。本研究通过比较加拿大新兴成年人队列中随着时间推移大麻使用频率及相关后果的变化,与美国一个未发生政策变化的司法管辖区内类似队列的变化,来评估大麻合法化的影响。
从安大略省汉密尔顿市和田纳西州孟菲斯市选取了两组新兴成年人样本,从2018年3月16日至2020年3月11日,以4个月为间隔进行纵向跟踪,在合法化前进行了三次评估,合法化后进行了四次评估。采用双重稳健的差分估计法来评估大麻合法化是否随着时间推移影响了加拿大样本中的大麻使用频率或与大麻相关的后果。大麻合法化对酒精使用及与酒精相关后果的影响也作为未发生政策变化的物质使用控制形式进行了评估。在差分估计中使用倾向得分平衡来调整队列差异。
与随着时间推移使用量普遍下降的趋势相反,差分估计显示,与美国样本相比,加拿大样本在合法化后约6个月(平均处理效应(95%置信区间):0.2245(0.0154,0.4336))和合法化后约一年(平均处理效应(95%置信区间):0.3091(0.0473,0.5709))时,大麻使用频率显著更高。在这两个时间点,加拿大样本中与大麻相关的后果也更大(平均处理效应(95%置信区间):0.7610(0.0797,1.4423)),(平均处理效应(95%置信区间):1.0396(0.1864,1.8928))。这些较高水平反映出随着时间推移下降幅度较小(即“成熟效应”减弱)。正如预期的那样,酒精使用情况在任何时间点都未显示出合法化的影响。
研究结果表明,与美国对照样本相比,在加拿大样本中,大麻合法化与大麻使用频率和不良后果的减少幅度小于预期有关。尽管这些影响的程度较小,但这些发现表明大麻发展轨迹开始出现分歧。鉴于合法化的影响被认为是长期的而非即时的,有必要进一步监测大麻合法化对大麻使用发展趋势及相关后果的影响。